IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 178 filers reported holding IMPAX LABORATORIES INC in Q4 2014. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $56,187,000 | -15.8% | 1,949,569 | -6.4% | 1.44% | -24.3% |
| Q1 2016 | $66,700,000 | -32.8% | 2,083,074 | -10.3% | 1.90% | -24.6% |
| Q4 2015 | $99,271,000 | -7.4% | 2,321,581 | -23.7% | 2.52% | +11.5% |
| Q3 2015 | $107,172,000 | -27.2% | 3,043,781 | -5.0% | 2.26% | -22.5% |
| Q2 2015 | $147,132,000 | +55.0% | 3,204,096 | +58.2% | 2.92% | +64.3% |
| Q1 2015 | $94,912,000 | +462.0% | 2,025,000 | +279.9% | 1.78% | +460.9% |
| Q4 2014 | $16,889,000 | – | 533,100 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |